Why developing new antibiotics is a matter of life and death
Antibiotic-resistant superbugs kill 700,000 people worldwide each year, but what's stopping the development of new treatments?
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:
Healthcare Delivery
Don't miss any update on this topic
Create a free account and access your personalized content collection with our latest publications and analyses.
License and Republishing
World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.
The views expressed in this article are those of the author alone and not the World Economic Forum.
The Agenda Weekly
A weekly update of the most important issues driving the global agenda
You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.
More on Healthcare DeliverySee all
Emma Farge
May 26, 2023
Shyam Bishen
May 25, 2023
Alicia Patterson-Waites
May 23, 2023
Jubilee Ahazie and Victoria Fan
May 12, 2023